the fight against the spread of COVID-19 is one of the most important challenges that we are currently facing throughout the world.
We at Genaxxon are pleased to be able to support your SARS-CoV-2 research with the recombinant SARS-CoV-2 (2019-nCoV) Spike S1 Protein (RBD) >. This receptor-binding domain with C-terminal His-Tag can be used as an antigen or control protein for analytic and diagnostic purposes, as well as for vaccine development to fight against COVID-19.
Spike (S) glycoprotein of SARS-CoV-2 coronavirus is essential for virus binding to the host cell at the beginning of the infective process. The S1 subunit distributed by Genaxxon contains a receptor-binding domain (RBD) that has a high affinity for the host angiotensin-converting enzyme 2 (ACE2) receptor.
